Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;7(3):216-219.
doi: 10.1159/000339686. Epub 2012 Jun 22.

Clinical Implications of Micrometastasis Detection in Internal Mammary Nodes of Breast Cancer Patients

Affiliations

Clinical Implications of Micrometastasis Detection in Internal Mammary Nodes of Breast Cancer Patients

Jian Zeng et al. Breast Care (Basel). 2012 Jun.

Abstract

BACKGROUND: The aim of this study was to assess the efficiency of step-serial sectioning (SSS) combined with hematoxylin and eosin (H&E) and immunohistochemical (IHC) staining in detecting micrometastasis of internal mammary lymph nodes (IMLNs). PATIENTS AND METHODS: 135 IMLNs from 88 breast cancer patients were re-examined by SSS, combined with either H&E or IHC staining of the biomarkers cytokeratin-19 and epithelial membrane antigen. RESULTS: Of the 135 IMLNs, 6 nodes from 5 cases displayed 1 or more micrometastases. Histological grade and lymphovascular invasion status were significantly correlated with micrometastasis in the IMLNs (p = 0.018 and 0.001, respectively). Of the 6 nodes positive for micrometastasis, 1 node was detected by both H&E and IHC staining. The remaining 5 nodes from 4 cases showed evident tumor cells only by IHC staining. Finally 8 of the 83 patients (9.64%) without IMLN metastasis showed distant metastasis, while 2 of the 5 patients (40%) with IMLN metastasis showed distant metastasis within 28 months of operation. CONCLUSION: SSS combined with H&E and IHC staining is more efficient in detecting micrometastasis than classic routine single-slice H&E only.

Hintergrund: Ziel dieser Studie war die Bestimmung der Effizienz des Step-Serial Sectioning (SSS) kombiniert mit Hämatoxylin-Eosin (H&E)-Färbung bzw. immunhistochemischer (IHC) Färbung zur Detektion von Mikrometastasen in den Mammaria-interna-Lymphknoten.

Patientinnen und Methoden: 135 Mammaria-interna-Lymphknoten von 88 Mammakarzinompatientinnen wurden mittels SSS kombiniert mit H&E- bzw. IHC-Färbung erneut auf die Biomarker Cytokeratin-19 und epitheliales Membranantigen untersucht.

Ergebnisse: Von den 135 Mammaria-interna-Lymphknoten zeigten 6 Knoten von 5 Fällen eine oder mehrere Mikrometastasen. Der histologische Grad und lymphovasku-läre Invasionsstatus waren signifikant mit dem Vorliegen von Mikrometastasen in den Mammaria-interna-Lymphknoten korreliert (p = 0,018 bzw. 0,001). Einer der 6 positiven Lymphknoten konnte sowohl mit H&E- als auch mit IHC-Färbung dargestellt werden. Für die verbleibenden 5 Knoten von 4 Fällen konnte nur die IHC-Färbung Tumorzellen nachweisen. Insgesamt zeigten 8 der 83 Patientinnen (9,64%) ohne Metastasen in den Mammaria-interna-Lymphknoten Fernmetastasen, während 2 der 5 Patientinnen (40%) mit Metastasen in den Mammaria-interna-Lymphknoten innerhalb von 28 Monaten nach Operation Fernmetastasen aufwiesen.

Schlussfolgerung: SSS kombiniert mit H&E- bzw. IHC-Färbung ist beim Aufzeigen von Mikrometastasen effektiver als die routinemäßig eingesetzte, klassische Single-Slice-H&E-Färbung.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Microscopy images of micrometastases in the parenchyma (CK-19, ×400).
Fig. 2
Fig. 2
Isolated tumor cells/clusters in the subcapsular sinuses (EMA, ×400).
Fig. 3
Fig. 3
Isolated tumor cells dispersed in a diffuse pattern in infiltrating lobular carcinoma (EMA, left ×100, central ×400), but stained negatively with H&E (right).

Similar articles

Cited by

References

    1. Anim JT, John B, et al. Relationship between the expression of various markers and prognostic factors in breast cancer. Acta Histochem. 2005;107:87–93. - PubMed
    1. Kasami M, Uematsu T, et al. Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy. Breast. 2008;17:523–527. - PubMed
    1. Jemal A, Siegel R, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66. - PubMed
    1. Gooiker GA, van Gijn W, et al. A systematic review and meta-analysis of the volume-outcome relationship in the surgical treatment of breast cancer. Are breast cancer patients better of with a high volume provider? Eur J Surg Oncol. 2010;36((suppl 1)):S27–35. - PubMed
    1. Chen JJ, Wu J. Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: with or without axillary lymph node dissection. Crit Rev Oncol Hematol. 2011;79:293–301. - PubMed